Dermacyd Infantile (Lactic Acid)- Compatibility.
Phase 4
Completed
- Conditions
- Hygiene
- Interventions
- Drug: LACTIC ACID(ND)
- Registration Number
- NCT00881374
- Lead Sponsor
- Sanofi
- Brief Summary
Primary Objective:
To demonstrate the absence of irritation potential (primary dermic irritability and cumulated dermic irritability) and allergic potential (sensibilization) of the product Dermacyd Infantile.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Dermacyd Infantile (Lactic Acid) LACTIC ACID(ND) six weeks treatment
- Primary Outcome Measures
Name Time Method The absence of primary and accumulated dermic irritability and dermic sensitivity will be evaluated using International Contact Dermatitis Research Group (ICDRG) scale. During 6 weeks (i.e. treatment period)
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Sanofi-Aventis Administrative Office
🇧🇷Sao Paulo, Brazil